Data from the CCK8 assay demonstrated that the knockdown of EphA2 led to the weakening of the proliferative capacity of cervical cancer cells, whereas the replenishment of CXCL11 leads to a significant recovery of the proliferative capacity of sh-EphA2-SiHa cells. Here, CXCL11 is linked to cervical cancer.